GlassScriptPhysician profile
Lashandra Mae Gilmore
NPI 1285336966
$2,192.86
in general payments reported to CMS, 2019-2025
19 companies · $854 in 2025
The $854 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $197 · 2024: $1,142 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,116 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,115.87 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $461.50 | 2024-2025 | Tremfya, Stelara |
| Abbvie INC. | $318.19 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $275.39 | 2023-2025 | Voquezna |
| Qol Medical, LLC | $189.69 | 2023-2025 | Sucraid, Sucraid |
| Lilly USA, LLC | $131.79 | 2024-2025 | Omvoh |
| Gilead Sciences, INC. | $113.17 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $93.60 | 2024-2025 | Entyvio, Eohilia, Gattex |
| Ardelyx, INC. | $83.86 | 2023-2024 | Ibsrela |
| Aimmune Therapeutics, INC. | $83.15 | 2024-2025 | Zenpep, Vowst |
| Celltrion USA INC. | $82.24 | 2024-2025 | Vegzelma |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.97 | 2023-2024 | Trulance, Xifaxan |
| Madrigal Pharmaceuticals | $68.12 | 2025 | Rezdiffra |
| Ipsen Biopharmaceuticals, INC | $52.70 | 2024-2025 | Iqirvo, Bylvay |
| Celgene Corporation | $38.45 | 2023-2024 | Zeposia |
| Pfizer INC. | $34.80 | 2024-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $25.20 | 2023 | Idacio |
| Redhill Biopharma INC. | $21.06 | 2023 | Talicia |
| Evoke Pharma, INC. | $21.00 | 2024 | |
| Nestle Healthcare Nutrition INC. | $19.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lashandra Gilmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.